ArticleBlood advances2026
Rat models of thrombotic thrombocytopenic purpura reveal crucial role of placental ADAMTS13 in perinatal survival.
Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
abstractThrombotic thrombocytopenic purpura (TTP), a life-threatening thrombotic microangiopathy, is caused by severe deficiency of plasma ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, 13) activity. Pregnancy is found to be frequently associated with the onset of acute TTP. However, how pregnancy or postpartum affects the progression of TTP and how ADAMTS13 may play a role in perinatal outcome are not known. Using CRISPR/CRISPR-associated protein 9, we generated a novel rat model of TTP by deleting 13 nucleotides in the coding region for ADAMTS13 metalloprotease domain. ADAMTS13-deficient (KO) rats showed barely detectable plasma ADAMTS13 activity, with a significantly increased size of plasma von Willebrand factor (VWF) multimers. The KO rats developed severe spontaneous thrombocytopenia, with a median platelet count of 125 × 109/L in heterozygous (Het) rats (P< .0001). Moreover, plasma levels of lactate dehydrogenase, urea nitrogen, and creatinine were significantly elevated in KO rats compared with those in WT (P< .05) and Het (P< .05) rats. Immunohistochemistry revealed the presence of VWF-rich and platelet integrin β3-rich microvascular thrombi in major organ tissues of KO rats but not of WT controls. Unexpectedly, pregnancy or postpartum did not result in worsening thrombocytopenia, but increased the risk of death in the KO females bred with KO male rats. These female rats produced significantly fewer live offsprings than those bred with WT or Het males (P< .05). We conclude that the findings in our novel KO rats recapitulate the features of congenital TTP and underscore the importance of fetal-placental ADAMTS13 in perinatal survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.